Birth Control May Lower MS Odds

NOVEMBER 01, 2005

Women taking oral contraceptives for 3 years saw a reduction in the odds of developing multiple sclerosis (MS). The study, as reported in the Archives of Neurology (September 2005), compared 106 women newly diagnosed with MS between January 1, 1993, and December 31, 2000, with 1001 women without the disease. The participants were chosen for the study based on a research database that included medical and pharmacy records for 3 million British patients.

"The incidence of MS in [oral contraceptive] users was 40% lower than in nonusers," the investigators reported. "Women had a higher risk of developing first symptoms of MS in the 6 months following a pregnancy and a nonsignificant lower risk during pregnancy, compared with those with no pregnancy.... This is consistent with studies on the effect of pregnancy in patients with MS and the immunological changes associated with pregnancy."


Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 


Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.